X0306 4 2020-04-24 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001197355 FUCHS HENRY J C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 0 1 0 0 President, Worldwide R&D Common Stock 2020-04-24 4 S 0 13642 95.3374 D 109014 D Common Stock 2020-04-24 4 S 0 3678 96.8492 D 105336 D Common Stock 2020-04-24 4 S 0 2680 97.3184 D 102656 D Trade made pursuant to a 10b5-1 plan executed on March 11, 2020. The price in column 4 is the weighted average price. The price actually received ranged from $95.015 to $95.99. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. The price in column 4 is the weighted average price. The price actually received ranged from $96.17 to $97.15. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. The price in column 4 is the weighted average price. The price actually received ranged from $97.17 to $97.50. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. /s/ Eric Fleekop, Attorney-in-Fact 2020-04-28